{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:44:19Z","timestamp":1793015059672,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM135234"],"award-info":[{"award-number":["R01GM135234"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI162779"],"award-info":[{"award-number":["R01AI162779"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE026728"],"award-info":[{"award-number":["R01DE026728"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI134972"],"award-info":[{"award-number":["R01AI134972"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM131399"],"award-info":[{"award-number":["R01GM131399"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI077283"],"award-info":[{"award-number":["R01AI077283"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA262089"],"award-info":[{"award-number":["R01CA262089"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1038\/s41590-022-01326-8","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T16:05:38Z","timestamp":1666281938000},"page":"1588-1599","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["SUSD2 suppresses CD8+ T cell antitumor immunity by targeting IL-2 receptor signaling"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3599-1230","authenticated-orcid":false,"given":"Bao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Velegraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Okimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9868-9824","authenticated-orcid":false,"given":"Yu L.","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiao","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3004-072X","authenticated-orcid":false,"given":"Kenneth J.","family":"Oestreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-8392","authenticated-orcid":false,"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-927X","authenticated-orcid":false,"given":"Zihai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6363-2748","authenticated-orcid":false,"given":"Haitao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"1326_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","volume":"37","author":"AJ Schoenfeld","year":"2020","unstructured":"Schoenfeld, A. J. & Hellmann, M. D. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 37, 443\u2013455 (2020).","journal-title":"Cancer Cell"},{"key":"1326_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41568-018-0081-9","volume":"19","author":"NK Altorki","year":"2019","unstructured":"Altorki, N. K. et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat. Rev. 19, 9\u201331 (2019).","journal-title":"Nat. Rev."},{"key":"1326_CR3","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"1326_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s41590-019-0512-0","volume":"20","author":"LP Andrews","year":"2019","unstructured":"Andrews, L. P., Yano, H. & Vignali, D. A. A. Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups. Nat. Immunol. 20, 1425\u20131434 (2019).","journal-title":"Nat. Immunol."},{"key":"1326_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi, A. & Ribas, A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat. Rev. Immunol. 20, 25\u201339 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1326_CR6","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan, D. A., Ruscetti, F. W. & Gallo, R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193, 1007\u20131008 (1976).","journal-title":"Science"},{"key":"1326_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2009.11.012","volume":"32","author":"ME Pipkin","year":"2010","unstructured":"Pipkin, M. E. et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32, 79\u201390 (2010).","journal-title":"Immunity"},{"key":"1326_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2009.11.010","volume":"32","author":"V Kalia","year":"2010","unstructured":"Kalia, V. et al. Prolonged interleukin-2R\u03b1 expression on virus-specific CD8+\u2009T cells favors terminal-effector differentiation in vivo. Immunity 32, 91\u2013103 (2010).","journal-title":"Immunity"},{"key":"1326_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"1326_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2019.03.028","volume":"50","author":"WJ Leonard","year":"2019","unstructured":"Leonard, W. J., Lin, J. X. & O\u2019Shea, J. J. The \u03b3c family of cytokines: basic biology to therapeutic ramifications. Immunity 50, 832\u2013850 (2019).","journal-title":"Immunity"},{"key":"1326_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.1117893","volume":"310","author":"X Wang","year":"2005","unstructured":"Wang, X., Rickert, M. & Garcia, K. C. Structure of the quaternary complex of interleukin-2 with its \u03b1, \u03b2, and \u03b3c receptors. Science 310, 1159\u20131163 (2005).","journal-title":"Science"},{"key":"1326_CR12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1126\/science.1109745","volume":"308","author":"M Rickert","year":"2005","unstructured":"Rickert, M., Wang, X., Boulanger, M. J., Goriatcheva, N. & Garcia, K. C. The structure of interleukin-2 complexed with its \u03b1 receptor. Science 308, 1477\u20131480 (2005).","journal-title":"Science"},{"key":"1326_CR13","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1126\/science.1122927","volume":"311","author":"O Boyman","year":"2006","unstructured":"Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924\u20131927 (2006).","journal-title":"Science"},{"key":"1326_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature04790","volume":"441","author":"MA Williams","year":"2006","unstructured":"Williams, M. A., Tyznik, A. J. & Bevan, M. J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441, 890\u2013893 (2006).","journal-title":"Nature"},{"key":"1326_CR15","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/eji.200637023","volume":"37","author":"MF Bachmann","year":"2007","unstructured":"Bachmann, M. F., Wolint, P., Walton, S., Schwarz, K. & Oxenius, A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur. J. Immunol. 37, 1502\u20131512 (2007).","journal-title":"Eur. J. Immunol."},{"key":"1326_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","volume":"26","author":"TR Malek","year":"2008","unstructured":"Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453\u2013479 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"1326_CR17","doi-asserted-by":"publisher","first-page":"702726","DOI":"10.3389\/fimmu.2021.702726","volume":"12","author":"EN Scott","year":"2021","unstructured":"Scott, E. N., Gocher, A. M., Workman, C. J. & Vignali, D. A. A. Regulatory T cells: barriers of immune infiltration into the tumor microenvironment. Front. Immunol. 12, 702726 (2021).","journal-title":"Front. Immunol."},{"key":"1326_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1349-7006.2007.00466.x","volume":"98","author":"T Sugahara","year":"2007","unstructured":"Sugahara, T. et al. Isolation of a novel mouse gene, mSVS-1\/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro. Cancer Sci. 98, 900\u2013908 (2007).","journal-title":"Cancer Sci."},{"key":"1326_CR19","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1021\/bi8006143","volume":"47","author":"M Souri","year":"2008","unstructured":"Souri, M., Kaetsu, H. & Ichinose, A. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly. Biochemistry 47, 8656\u20138664 (2008).","journal-title":"Biochemistry"},{"key":"1326_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1158\/1541-7786.MCR-12-0501-T","volume":"11","author":"AP Watson","year":"2013","unstructured":"Watson, A. P., Evans, R. L. & Egland, K. A. Multiple functions of sushi domain containing 2 (SUSD2) in breast tumorigenesis. Mol. Cancer Res. 11, 74\u201385 (2013).","journal-title":"Mol. Cancer Res."},{"key":"1326_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep06812","volume":"4","author":"W Pan","year":"2014","unstructured":"Pan, W. et al. CSBF\/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest. Sci. Rep. 4, 6812 (2014).","journal-title":"Sci. Rep."},{"key":"1326_CR22","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.3892\/ol.2015.3737","volume":"10","author":"C Cai","year":"2015","unstructured":"Cai, C. et al. Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer. Oncol. Lett. 10, 3619\u20133624 (2015).","journal-title":"Oncol. Lett."},{"key":"1326_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.64","volume":"5","author":"JN Sheets","year":"2016","unstructured":"Sheets, J. N. et al. SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance. Oncogenesis 5, e264 (2016).","journal-title":"Oncogenesis"},{"key":"1326_CR24","doi-asserted-by":"publisher","first-page":"e0177089","DOI":"10.1371\/journal.pone.0177089","volume":"12","author":"EM Hultgren","year":"2017","unstructured":"Hultgren, E. M., Patrick, M. E., Evans, R. L., Stoos, C. T. & Egland, K. A. SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer. PLoS ONE 12, e0177089 (2017).","journal-title":"PLoS ONE"},{"key":"1326_CR25","doi-asserted-by":"publisher","first-page":"e0183681","DOI":"10.1371\/journal.pone.0183681","volume":"12","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells. PLoS ONE 12, e0183681 (2017).","journal-title":"PLoS ONE"},{"key":"1326_CR26","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1002\/cam4.1793","volume":"7","author":"S Umeda","year":"2018","unstructured":"Umeda, S. et al. Expression of sushi domain containing two reflects the malignant potential of gastric cancer. Cancer Med. 7, 5194\u20135204 (2018).","journal-title":"Cancer Med."},{"key":"1326_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1084\/jem.20161105","volume":"214","author":"X Li","year":"2017","unstructured":"Li, X. et al. Myeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation. J. Exp. Med. 214, 1093\u20131109 (2017).","journal-title":"J. Exp. Med."},{"key":"1326_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457\u2013495 (2019).","journal-title":"Annu. Rev. Immunol."},{"key":"1326_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"1326_CR30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision. Immunity 51, 840\u2013855 (2019).","journal-title":"Immunity"},{"key":"1326_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.11.002","volume":"51","author":"WH Hudson","year":"2019","unstructured":"Hudson, W. H. et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity 51, 1043\u20131058 (2019).","journal-title":"Immunity"},{"key":"1326_CR32","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander, R. et al. CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity 51, 1028\u20131042 (2019).","journal-title":"Immunity"},{"key":"1326_CR33","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1172\/JCI96113","volume":"128","author":"H Lin","year":"2018","unstructured":"Lin, H. et al. Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression. J. Clin. Invest. 128, 805\u2013815 (2018).","journal-title":"J. Clin. Invest."},{"key":"1326_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1182\/blood-2007-08-106443","volume":"111","author":"H Wen","year":"2008","unstructured":"Wen, H., Dou, Y., Hogaboam, C. M. & Kunkel, S. L. Epigenetic regulation of dendritic cell-derived interleukin-12 facilitates immunosuppression after a severe innate immune response. Blood 111, 1797\u20131804 (2008).","journal-title":"Blood"},{"key":"1326_CR35","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41586-021-03861-0","volume":"597","author":"F Mo","year":"2021","unstructured":"Mo, F. et al. An engineered IL-2 partial agonist promotes CD8(+) T cell stemness. Nature 597, 544\u2013548 (2021).","journal-title":"Nature"},{"key":"1326_CR36","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat. Rev. Immunol. 18, 648\u2013659 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1326_CR37","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1073\/pnas.1002569107","volume":"107","author":"C Krieg","year":"2010","unstructured":"Krieg, C., Letourneau, S., Pantaleo, G. & Boyman, O. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc. Natl Acad. Sci. USA 107, 11906\u201311911 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1326_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.immuni.2015.04.015","volume":"42","author":"JB Spangler","year":"2015","unstructured":"Spangler, J. B. et al. Antibodies to interleukin-2 elicit selective T cell subset potentiation through distinct conformational mechanisms. Immunity 42, 815\u2013825 (2015).","journal-title":"Immunity"},{"key":"1326_CR39","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41586-019-0985-x","volume":"567","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530\u2013534 (2019).","journal-title":"Nature"},{"key":"1326_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cmet.2022.02.009","volume":"34","author":"L Ye","year":"2022","unstructured":"Ye, L. et al. A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy. Cell Metab. 34, 595\u2013614 (2022).","journal-title":"Cell Metab."},{"key":"1326_CR41","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1001\/jama.1986.03380220083027","volume":"256","author":"MT Lotze","year":"1986","unstructured":"Lotze, M. T. et al. High-dose recombinant interleukin 2 in the treatment of patients with disseminated cancer. Responses, treatment-related morbidity, and histologic findings. JAMA 256, 3117\u20133124 (1986).","journal-title":"JAMA"},{"key":"1326_CR42","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850\u2013854 (2002).","journal-title":"Science"},{"key":"1326_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto, M. et al. CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev. Med. 69, 301\u2013318 (2018).","journal-title":"Annu Rev. Med."},{"key":"1326_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.immuni.2020.04.014","volume":"52","author":"JC Beltra","year":"2020","unstructured":"Beltra, J. C. et al. Developmental relationships of four exhausted CD8(+) T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms. Immunity 52, 825\u2013841 e828 (2020).","journal-title":"Immunity"},{"key":"1326_CR45","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1172\/JCI67008","volume":"123","author":"EE West","year":"2013","unstructured":"West, E. E. et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 123, 2604\u20132615 (2013).","journal-title":"J. Clin. Invest."},{"key":"1326_CR46","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1084\/jem.20101138","volume":"207","author":"H Wen","year":"2010","unstructured":"Wen, H., Lei, Y., Eun, S. Y. & Ting, J. P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 207, 2943\u20132957 (2010).","journal-title":"J. Exp. Med."},{"key":"1326_CR47","doi-asserted-by":"publisher","unstructured":"Kwon, H. et al. Androgen conspires with the CD8(+) T cell exhaustion program and contributes to sex bias in cancer. Sci. Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abq2630 (2022).","DOI":"10.1126\/sciimmunol.abq2630"},{"key":"1326_CR48","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636\u2013645 (2015).","journal-title":"Cytom. A"},{"key":"1326_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2016.154","volume":"12","author":"R Zilionis","year":"2017","unstructured":"Zilionis, R. et al. Single-cell barcoding and sequencing using droplet microfluidics. Nat. Protoc. 12, 44\u201373 (2017).","journal-title":"Nat. Protoc."},{"key":"1326_CR50","doi-asserted-by":"publisher","first-page":"D680","DOI":"10.1093\/nar\/gkl898","volume":"35","author":"D Zuo","year":"2007","unstructured":"Zuo, D. et al. PlasmID: a centralized repository for plasmid clone information and distribution. Nucleic Acids Res. 35, D680\u2013D684 (2007).","journal-title":"Nucleic Acids Res."},{"key":"1326_CR51","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1021\/acs.jproteome.9b00037","volume":"18","author":"YH Lin","year":"2019","unstructured":"Lin, Y. H. et al. Self-assembled STrap for global proteomics and salivary biomarker discovery. J. Proteome Res. 18, 1907\u20131915 (2019).","journal-title":"J. Proteome Res."},{"key":"1326_CR52","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S., Temu, T. & Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat. Protoc. 11, 2301\u20132319 (2016).","journal-title":"Nat. Protoc."},{"key":"1326_CR53","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2010-01-265041","volume":"116","author":"JN Kochenderfer","year":"2010","unstructured":"Kochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P. & Rosenberg, S. A. Adoptive transfer of syngeneic T cells transduced with a chimeric antigen receptor that recognizes murine CD19 can eradicate lymphoma and normal B cells. Blood 116, 3875\u20133886 (2010).","journal-title":"Blood"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01326-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01326-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T01:16:09Z","timestamp":1668647769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-022-01326-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1038\/s41590-022-01326-8","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}